Home > Compound List > Compound details
479-41-4 molecular structure
click picture or here to close

3-(3-oxo-2,3-dihydro-1H-indol-2-ylidene)-2,3-dihydro-1H-indol-2-one

ChemBase ID: 73010
Molecular Formular: C16H10N2O2
Molecular Mass: 262.2628
Monoisotopic Mass: 262.07422757
SMILES and InChIs

SMILES:
c1ccc2c(c1)NC(=O)/C/2=C\1/Nc2c(C1=O)cccc2
Canonical SMILES:
O=C1/C(=C/2\C(=O)Nc3c2cccc3)/Nc2c1cccc2
InChI:
InChI=1S/C16H10N2O2/c19-15-10-6-2-4-8-12(10)17-14(15)13-9-5-1-3-7-11(9)18-16(13)20/h1-8,17H,(H,18,20)/b14-13+
InChIKey:
CRDNMYFJWFXOCH-BUHFOSPRSA-N

Cite this record

CBID:73010 http://www.chembase.cn/molecule-73010.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
3-(3-oxo-2,3-dihydro-1H-indol-2-ylidene)-2,3-dihydro-1H-indol-2-one
IUPAC Traditional name
3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one
Synonyms
Indirubin
CAS Number
479-41-4
PubChem SID
162037930
PubChem CID
5359405

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price
Selleck Chemicals
S2386 external link Add to cart Please log in.
Data Source Data ID
PubChem 5359405 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 7.41985  H Acceptors
H Donor LogD (pH = 5.5) 2.429935 
LogD (pH = 7.4) 2.1638434  Log P 2.434867 
Molar Refractivity 78.9954 cm3 Polarizability 28.034647 Å3
Polar Surface Area 58.2 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Storage Condition
-20°C expand Show data source
Target
GSK-3 expand Show data source
Salt Data
Free Base expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S2386 external link
Research Area: Cancer
Biological Activity:
Indirubin is a potent cyclin-dependent kinases and GSK-3β inhibitor with IC50 of about 75 nM and 0.19 μM. It inhibits CDK5- and GSK-3β-mediated tau phosphorylation, a process over-active in Alzheimer disease states. Also inhibits AMPK, LCK and SGK. Induces cell cycle arrest and inhibits cell proliferation. It suppressed tumor necrosis factor (TNF)-induced NF-κB activation in a dose- and time-dependent manner. Indirubin also suppressed the NF-κB activation induced by various inflammatory agents and carcinogens. Further studies showed that indirubin blocked the phosphorylation and degradation of IκBα through the inhibition of activation of IκBα kinase and phosphorylation and nuclear translocation of p65. NF-κB reporter activity induced by TNFR1, TNF receptor-associated death domain, TRAF2, TAK1, NF-κB-inducing kinase, and IKKβ was inhibited by indirubin but not that induced by p65 transfection. [1][2]References on Indirubin[1] NATURE CELL BIOLOGY, MAY 1999, 1:60-67[2] THE JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276:251–260

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • Hoessel R et al. Nat Cell Biol. 1999 May;1(1):60-7.
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle